SummaryAppetite suppression from GLP-1 drugs can create nutritional gaps, with potential consequences such as irreversible nerve damage, including peripheral neuropathy and cognitive impairment. Unaddressed deficiencies among consumers can cause tingling, numbness, brain fog and unexplained fatigue.